Skip to content
  • About
  • Contact
  • Contribute
  • My Book
  • Careers
  • Podcast
  • Transcripts
  • Speaking
KevinMD
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
    • All
    • Physician
    • Burnout
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • About
    • Contact
    • Contribute
    • My Book
    • Careers
    • Podcast
    • Transcripts
    • Speaking
KevinMD
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
    • All
    • Physician
    • Burnout
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • About
    • Contact
    • Contribute
    • My Book
    • Careers
    • Podcast
    • Transcripts
    • Speaking
  • About Kevin Pho, MD, Founder of KevinMD
  • Be heard on social media’s leading physician voice
  • Contact Kevin
  • Custom enhanced author page pricing
  • DMCA Policy
  • Establishing, Managing, and Protecting Your Online Reputation: A Social Media Guide for Physicians and Medical Practices
  • KevinMD influencer opportunities
  • Opinion and commentary by KevinMD
  • Physician burnout speakers to keynote your conference
  • Physician Coaching by KevinMD
  • Physician keynote speaker: Kevin Pho, MD
  • Physician Speaking by KevinMD: a boutique speakers bureau
  • Primary care physician in Nashua, NH | Kevin Pho, MD
  • Privacy Policy
  • Recommended services by KevinMD
  • Terms of Use Agreement
  • Thank you for subscribing to KevinMD
  • Thank you for upgrading to the KevinMD enhanced author page
  • Upgrade to the KevinMD enhanced author page

Should the FDA have rejected Contrave?

Daniel J. Carlat, MD
Medications
April 13, 2011
Share
Tweet
Share

Recently, the FDA has rejected another anti-obesity drug, Contrave, because of concerns that it might cause heart attacks in patients who take it for years.

FDA’s excessive caution was motivated by its experience having been burned by the Fen-Phen fiasco. This was a weight loss drug widely prescribed in the 90s that was pulled from the market after studies showed it caused fatal lung and heart valve problems.

This new drug, however, is a combination of two medications that have already been widely prescribed and are fairly safe: Wellbutrin and naltrexone. Psychiatrists are familiar with both of them. We prescribe Wellbutrin for depression and smoking cessation, (and off-label for weight loss, for which it has shown efficacy as a stand alone), and we prescribe naltrexone for alcoholism.

As you can see from information published on Clinicaltrials.gov, Contrave is simply a combination of Wellbutrin 400 mg with Naltrexone at a couple of different doses, 48 mg and 16 mg. Clinical trials showed that Contrave helped 50% of obese patients lose 5% of their body weight, while only 10% of patients on placebo lost that much weight. The FDA’s advisory panel voted to recommend approval, but the FDA demurred, saying that the company, Orexigen, will have to conduct a huge placebo-controlled long term study to make sure the drug doesn’t cause heart attacks (one of Wellbutrin’s well-known side effects is a slight increase in pulse and blood pressure, although there were no heart attacks in the Contrave clincial trials).

In my opinion, the FDA made the wrong decision. Obesity is a public health catastrophe, and Contrave’s approval would have been predicated on conducting post-marketing safety studies anyway. The good news is that patients can ask doctors to prescribe them the constituents of Contrave, both of which are available in generic form–burpropion and naltrexone. Presumably, this generic combination will be much cheaper than Contrave’s pricing anyway.

Daniel Carlat is a psychiatrist and author of Unhinged: The trouble with psychiatry- a doctor’s revelations about a profession in crisis.

Submit a guest post and be heard on social media’s leading physician voice.

Prev

USA Today op-ed on end of life care and advance directives

April 13, 2011 Kevin 1
…
Next

Policies prohibiting collaboration between physicians and industry

April 13, 2011 Kevin 3
…

Tagged as: Medications and Prescribing

< Previous Post
USA Today op-ed on end of life care and advance directives
Next Post >
Policies prohibiting collaboration between physicians and industry

ADVERTISEMENT

More by Daniel J. Carlat, MD

  • a desk with keyboard and ipad with the kevinmd logo

    Elimination of industry support for CME

    Daniel J. Carlat, MD
  • a desk with keyboard and ipad with the kevinmd logo

    The decision point psychiatrists faced with psychotherapy

    Daniel J. Carlat, MD
  • a desk with keyboard and ipad with the kevinmd logo

    ProPublica’s Dollars for Docs: Strengths and weaknesses

    Daniel J. Carlat, MD

More in Medications

  • Is anticoagulation bleeding risk worse in the real world?

    David K. Cundiff, MD
  • Heparin for acute coronary syndrome: a closer look

    David K. Cundiff, MD
  • 5 ways drug ads mislead patients on TV

    M. Bennet Broner, PhD
  • Peptide regulation: 4 lanes every physician must know

    Benjamin González, MD
  • Why physicians need to learn cannabis medicine now

    Janice Makela, MD
  • Medication adherence is a communication problem

    Vimal Patel, RPh
  • Most Popular

  • Past Week

    • The MCAT requirement persists as a norm, not as a tool

      Aniruth Ananthanarayanan | Medical Education
    • DEA fear is reshaping how doctors prescribe

      Ronald L. Lindsay, MD | Physician
    • The double standard at the heart of chronic pain treatment

      Joshua Saylor | Conditions and Diseases
    • Your sinus infection may not be an infection

      Franklyn R. Gergits, DO, MBA | Conditions and Diseases
    • Why scientific medicine alone is not making us healthier

      Narinder Singh Parhar, MD | Physician
    • 20 years inside a Medicare Advantage insurer, and who actually pays [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Primary care crisis requires new training and skills

      Justin Oldfield, MD | Physician
    • The MCAT requirement persists as a norm, not as a tool

      Aniruth Ananthanarayanan | Medical Education
    • Polycystic ovary syndrome is more than ovarian

      Oluyemisi Famuyiwa, MD | Conditions and Diseases
    • DEA fear is reshaping how doctors prescribe

      Ronald L. Lindsay, MD | Physician
    • Physician retirement is a myth for the ripening doctor

      Farid Sabet-Sharghi, MD | Physician
    • Primary care access is the real problem, not the system

      Payam Zamani, MD | Physician
  • Recent Posts

    • 20 years inside a Medicare Advantage insurer, and who actually pays [PODCAST]

      The Podcast by KevinMD | Podcast
    • Fear of cancer recurrence is a human response, not a flaw

      Jae L. Ross, PsyD | Conditions and Diseases
    • The attention economy is starving public health

      Paul Dranichnikov, MD, PhD | Physician
    • Mental health ghost networks are badly hurting patients

      Steve Cohen, JD | Conditions and Diseases
    • 3 changes physicians on social media need from institutions

      Trisha Majumdar | Social Media in Medicine
    • Why your overhead percentage is the wrong benchmark

      GetPracticeHelp | Physician Finance

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 6 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The MCAT requirement persists as a norm, not as a tool

      Aniruth Ananthanarayanan | Medical Education
    • DEA fear is reshaping how doctors prescribe

      Ronald L. Lindsay, MD | Physician
    • The double standard at the heart of chronic pain treatment

      Joshua Saylor | Conditions and Diseases
    • Your sinus infection may not be an infection

      Franklyn R. Gergits, DO, MBA | Conditions and Diseases
    • Why scientific medicine alone is not making us healthier

      Narinder Singh Parhar, MD | Physician
    • 20 years inside a Medicare Advantage insurer, and who actually pays [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Primary care crisis requires new training and skills

      Justin Oldfield, MD | Physician
    • The MCAT requirement persists as a norm, not as a tool

      Aniruth Ananthanarayanan | Medical Education
    • Polycystic ovary syndrome is more than ovarian

      Oluyemisi Famuyiwa, MD | Conditions and Diseases
    • DEA fear is reshaping how doctors prescribe

      Ronald L. Lindsay, MD | Physician
    • Physician retirement is a myth for the ripening doctor

      Farid Sabet-Sharghi, MD | Physician
    • Primary care access is the real problem, not the system

      Payam Zamani, MD | Physician
  • Recent Posts

    • 20 years inside a Medicare Advantage insurer, and who actually pays [PODCAST]

      The Podcast by KevinMD | Podcast
    • Fear of cancer recurrence is a human response, not a flaw

      Jae L. Ross, PsyD | Conditions and Diseases
    • The attention economy is starving public health

      Paul Dranichnikov, MD, PhD | Physician
    • Mental health ghost networks are badly hurting patients

      Steve Cohen, JD | Conditions and Diseases
    • 3 changes physicians on social media need from institutions

      Trisha Majumdar | Social Media in Medicine
    • Why your overhead percentage is the wrong benchmark

      GetPracticeHelp | Physician Finance

MedPage Today Professional

An Everyday Health Property Medpage Today

Copyright © 2026 KevinMD.com | Powered by Astra WordPress Theme

  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Should the FDA have rejected Contrave?
6 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...